Evestia Clinical Acquires Belgian Medical Writing Specialist Emtex Life Science to Expand European CRO Presence
AKEURA Launches as Specialist CRO Combining Clinical Development and Real-World Evidence After P95 and Julius Clinical Integration
Transpharmation Acquires OrganoTherapeutics to Combine Translational In Vivo CRO Expertise With Human Stem Cell-Derived Organoid Technology Read more
LGM Pharma Acquires Sannova Analytical to Expand GLP Bioanalytical and cGMP Testing Services Read more
Fortrea and Omico Collaborate to Connect Genomically Profiled Patients With Biomarker-Led CRO Oncology Trials in Australia Read more
Marvel Biosciences Signs LOI With Novotech CRO for Phase 1 First-in-Human Trial of MB-204 in Australia Read more
Quantum BioPharma Signs Phase 2 Study Start-Up Agreement With Thermo Fisher’s PPD CRO for First-in-Class MS Candidate Lucid-MS Read more
CellCarta and Imagene AI Expand CRO Collaboration to Validate and Deploy AI-Powered Biomarker and CDx Programs With Leading Pharma Partners Read more
Emerald Clinical Trials Appoints Former Novotech COO Michael Stibilj as CEO to Lead Next Phase of Asia-Pacific CRO Growth Read more
BioToxTech Targets 200% Growth in U.S. and European Non-Clinical CRO Orders With Bundled Turnkey Package Model Read more
Parexel Launches FSP Integrated Solutions to Move Beyond Headcount-Based CRO Outsourcing With AI-Enabled Outcomes Model Read more
WELL Health Launches WELL Research as Integrated CRO, SMO, and Bioanalytical Platform Built on Canada’s Largest Outpatient Network Read more
Everest Clinical Research Acquires Firma Clinical Research’s Data Services Unit to Expand Global Biometrics CRO Capabilities Read more
Oncodesign Services and Nexus BioQuest Partner to Give Biotech Sponsors a Clearer Route to Specialist Preclinical CRO Expertise Read more
Sygnature Discovery Formalizes DEL Screening CRO Collaboration With X-Chem to Widen Hit-Finding Options for Drug Discovery Programs Read more
McKesson Acquires Global CRO Precision Medicine Group for $2.25B to Deepen Oncology Clinical Research Capabilities Read more
Alpha Genesis Launches AGI Ventures With $50M Commitment to Co-Invest in Biotech Programs Through Its Preclinical CRO Platform Read more
Fortrea Acquires Worldwide Clinical Trials’ Early Phase Division for $45M to Add 200-Bed CPU and GLP Bioanalytical Lab Read more